SPOTLIGHT: Cancer cost hike tempered by generics


The average annual drug cost per cancer patient has reached new highs--$13,113 as of January 1, compared with $6,490 in 2001--but a new report shows that generics are being used more often, helping to slow the rate of that cost increase. Report